Delivery Order SPE2DB24D2012-SPE2DB24FBVNJ

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $4,484.43 firm-fixed-price contract is for the delivery of M-M-R II vaccine vials, with an ultimate completion date of May 30, 2024. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,706.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of M-M-R II vaccine vials and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,024.76 and a completion date of April 17, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of M-M-R II vaccine vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract has a ceiling value of $10,940.26 and a period of performance through March 29, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,170.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of M-M-R II vaccine vials. The $1,537.14 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract worth $5,123.90 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of M-M-R II vaccine vials, a critical medical product, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $6,858.65, is for the delivery of M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB24FBVNJ
    Delivery Order

The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,184.03 fixed-price contract is for the supply of M-M-R II vaccine vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 19, 2024.

Generated 11/15/24, 9:28 AM